Armistice Capital’s Ocugen OCGN Stock Holding History

Armistice Capital’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,067	Closed	-$2.11M	–	53
2016 Q4	$2.11M	Buy	21,067 +16,644	+376%	+$2.31M	0.5%	43
2016 Q3	$852K	Buy	+4,423	New	+$692K	0.27%	42

Other funds holding OCGN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

SMV

Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carl Domino West Palm Beach, Florida $82M AUM 19.36% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Armistice Capital's OCGN Position: Q1 2017 in Review

Armistice Capital sold out of Ocugen (OCGN) in Q1 2017, closing a stake of 21,067 shares — an estimated $2.11M sold.

Armistice Capital first reported a position in OCGN in Q3 2016 and held it in 2 quarters. The position peaked at $2.11M in Q4 2016. 25 funds tracked by Wall St. Rank hold OCGN as of Q1 2017.

Armistice Capital reported no remaining Ocugen position as of Q1 2017 after selling out during the quarter.
Armistice Capital sold 21,067 Ocugen shares in Q1 2017, an estimated $2.11M.
Armistice Capital first reported a position in Ocugen in Q3 2016 and held it in 2 quarters.
Armistice Capital's Ocugen position peaked at $2.11M in Q4 2016.
25 funds tracked by Wall St. Rank held Ocugen as of Q1 2017.

Based on Armistice Capital's 13F filing for Q1 2017, filed 15 May 2017.